newsfilter
← Latest News
GlobeNewswire·

BioCardia to Host Q3 2026 Financial Results and Corporate Update Conference Call on November 12, 2026

  • BioCardia, Inc. will provide a corporate update & report financial results for the third quarter of 2026 via conference call on Thursday, November 12, 2026, at 4:30 PM EDT.
  • The event includes formal management remarks followed by a question-and-answer session.
  • Registration for the conference is available at the provided DPRegister link, with dial-in numbers sent upon registration.
  • Unregistered U.S. callers may dial 1-833-316-0559 & international callers may dial 1-412-317-5730, arriving 10 minutes prior to the start time.
  • A live webcast is accessible via the provided Choruscall link, with a replay available approximately one hour after the call ends through November 12, 2026.
  • Telephonic replays are accessible by dialing 1-855-669-9658 (domestic/Canada) or 1-412-317-0088 (international) using access code 8587782.
  • BioCardia is a Sunnyvale, California-based company focused on cellular & cell-derived therapeutics for cardiovascular & pulmonary diseases.
  • The company's biotherapeutic platforms include CardiAMP® autologous & CardiALLO™ allogeneic cell therapies, with three cardiac clinical-stage candidates in development.
  • Development is supported by Helix™ biotherapeutic delivery, Morph® vascular navigation, & the under-development Heart3D™ fusion imaging platforms.
  • Investor relations inquiries can be directed to Miranda Peto, while financial inquiries should be sent to Chief Financial Officer David McClung.
Company
BioCardia, Inc.
Keywords
Nasdaq:BCDA, BioCardia, Inc., $BCDA, #earningsannoucement, #Q32026earnings